-
Je něco špatně v tomto záznamu ?
Physiological influence of tylosin tartrate overdose in vivo in rats
JeongWoo Kang, Akil Hossain, Hae-chul Park, Tae-wan Kim, Sang-Hee Jeong
Jazyk angličtina Země Česko
Typ dokumentu klinická studie, práce podpořená grantem
- MeSH
- antibakteriální látky klasifikace škodlivé účinky toxicita MeSH
- hodnocení léčiv * metody veterinární MeSH
- nežádoucí účinky léčiv veterinární MeSH
- potkani Wistar metabolismus MeSH
- testy toxicity metody veterinární MeSH
- tylosin * aplikace a dávkování škodlivé účinky toxicita MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- klinická studie MeSH
- práce podpořená grantem MeSH
The aim of this study was to evaluate the physiological effects of tylosin in rats. Tylosin was administered orally to pubertal male and female rats at concentrations of 0.005, 0.2, 10 and 200 mg/kg b.w. for 6 weeks. The overall body and organ weights were recorded. Serum levels of immunoglobulins, haematological values, histopathological lesions in different organs, and gene expression profiles in pituitary glands were investigated. The mean platelet volume was increased, and the monocyte count was decreased significantly in both male and female rats treated with tylosin. Compared to the untreated control, alanine transaminase in both types of rats and total serum bilirubin in female rats were increased significantly with the administration of tylosin (200 mg/kg), however, lactate dehydrogenase in female rats was decreased. The levels of immunoglobulin M were reduced in both male and female rats but immunoglobulin G levels were significantly reduced only in female rats which were treated with tylosin. Cell proliferation- and adhesion-associated genes were expressed more but apoptosis gene expressions were decreased in the pituitary gland of tylosin-treated rats. In conclusion, this study revealed that the use of tylosin at therapeutic dosage is possibly not completely safe.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21017186
- 003
- CZ-PrNML
- 005
- 20241210111932.0
- 007
- cr|cn|
- 008
- 210716s2020 xr ad fs 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2754/avb202089030283 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kang, JeongWoo $u Veterinary drugs & Biologics Division, Animal and Plant Quarantine Agency (APQA), Gimcheon-si, Gyeongsangbuk-do, Republic of Korea
- 245 10
- $a Physiological influence of tylosin tartrate overdose in vivo in rats / $c JeongWoo Kang, Akil Hossain, Hae-chul Park, Tae-wan Kim, Sang-Hee Jeong
- 504 __
- $a Literatura
- 520 9_
- $a The aim of this study was to evaluate the physiological effects of tylosin in rats. Tylosin was administered orally to pubertal male and female rats at concentrations of 0.005, 0.2, 10 and 200 mg/kg b.w. for 6 weeks. The overall body and organ weights were recorded. Serum levels of immunoglobulins, haematological values, histopathological lesions in different organs, and gene expression profiles in pituitary glands were investigated. The mean platelet volume was increased, and the monocyte count was decreased significantly in both male and female rats treated with tylosin. Compared to the untreated control, alanine transaminase in both types of rats and total serum bilirubin in female rats were increased significantly with the administration of tylosin (200 mg/kg), however, lactate dehydrogenase in female rats was decreased. The levels of immunoglobulin M were reduced in both male and female rats but immunoglobulin G levels were significantly reduced only in female rats which were treated with tylosin. Cell proliferation- and adhesion-associated genes were expressed more but apoptosis gene expressions were decreased in the pituitary gland of tylosin-treated rats. In conclusion, this study revealed that the use of tylosin at therapeutic dosage is possibly not completely safe.
- 650 17
- $a tylosin $x aplikace a dávkování $x škodlivé účinky $x toxicita $7 D015645 $2 czmesh
- 650 _7
- $a potkani Wistar $x metabolismus $7 D017208 $2 czmesh
- 650 _7
- $a testy toxicity $x metody $x veterinární $7 D018675 $2 czmesh
- 650 _7
- $a nežádoucí účinky léčiv $x veterinární $7 D064420 $2 czmesh
- 650 _7
- $a antibakteriální látky $x klasifikace $x škodlivé účinky $x toxicita $7 D000900 $2 czmesh
- 650 17
- $a hodnocení léčiv $x metody $x veterinární $7 D004341 $2 czmesh
- 650 _7
- $a zvířata $7 D000818 $2 czmesh
- 655 _7
- $a klinická studie $7 D000068397 $2 czmesh
- 655 _7
- $a práce podpořená grantem $7 D013485 $2 czmesh
- 700 1_
- $a Hossain, Akil $u Veterinary drugs & Biologics Division, Animal and Plant Quarantine Agency (APQA), Gimcheon-si, Gyeongsangbuk-do, Republic of Korea
- 700 1_
- $a Park, Hae-chul $u Veterinary drugs & Biologics Division, Animal and Plant Quarantine Agency (APQA), Gimcheon-si, Gyeongsangbuk-do, Republic of Korea
- 700 1_
- $a Kim, Tae-wan $u Department of Physiology, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea
- 700 1_
- $a Jeong, Sang-Hee $u GLP Research Center, College of Natural Sciences, Hoseo University, Asan City, Republic of Korea
- 773 0_
- $t Acta veterinaria Brno $x 0001-7213 $g Roč. 89, č. 3 (2020), s. 283-290 $w MED00172332
- 856 41
- $u https://actavet.vfu.cz/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b online $y p $z 0
- 990 __
- $a 20210716112053 $b ABA008
- 991 __
- $a 20241210111929 $b ABA008
- 999 __
- $a ok $b bmc $g 1672180 $s 1137621
- BAS __
- $a 3 $a 4
- BMC __
- $a 2020 $b 89 $c 3 $d 283-290 $i 0001-7213 $m Acta veterinaria Brno $x MED00172332
- LZP __
- $c NLK193 $d 20240620 $a NLK 2021-04/kv
